10.32
price up icon0.49%   0.05
after-market アフターアワーズ: 10.31 -0.010 -0.10%
loading
前日終値:
$10.27
開ける:
$10.34
24時間の取引高:
1.04M
Relative Volume:
0.80
時価総額:
$559.18M
収益:
$1.02B
当期純損益:
$-757.20M
株価収益率:
-0.6992
EPS:
-14.76
ネットキャッシュフロー:
$-257.90M
1週間 パフォーマンス:
+24.79%
1か月 パフォーマンス:
+11.09%
6か月 パフォーマンス:
+36.87%
1年 パフォーマンス:
+337.29%
1日の値動き範囲:
Value
$9.89
$10.53
1週間の範囲:
Value
$8.26
$10.53
52週間の値動き範囲:
Value
$1.42
$15.10

Emergent Biosolutions Inc Stock (EBS) Company Profile

Name
名前
Emergent Biosolutions Inc
Name
セクター
Healthcare (1174)
Name
電話
240-631-3200
Name
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
Name
職員
1,600
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
EBS's Discussions on Twitter

EBS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EBS
Emergent Biosolutions Inc
10.32 559.18M 1.02B -757.20M -257.90M -14.76
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.31 73.68B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.46 42.77B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.26 42.04B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
21.24 24.07B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
12.28 14.66B 15.05B -883.30M 1.89B -0.74

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-30 開始されました H.C. Wainwright Buy
2024-08-22 開始されました Rodman & Renshaw Buy
2024-03-07 アップグレード The Benchmark Company Hold → Buy
2023-11-20 再開されました JP Morgan Underweight
2023-08-29 ダウングレード The Benchmark Company Buy → Hold
2023-04-10 アップグレード The Benchmark Company Hold → Buy
2023-03-17 ダウングレード JP Morgan Neutral → Underweight
2022-11-10 ダウングレード The Benchmark Company Buy → Hold
2022-04-29 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-01-20 アップグレード The Benchmark Company Hold → Buy
2021-11-08 ダウングレード The Benchmark Company Buy → Hold
2021-05-05 ダウングレード Argus Buy → Hold
2021-04-07 開始されました The Benchmark Company Buy
2021-02-24 アップグレード Chardan Capital Markets Neutral → Buy
2021-02-19 ダウングレード Chardan Capital Markets Buy → Neutral
2021-01-08 ダウングレード Wells Fargo Overweight → Equal Weight
2020-09-14 再開されました JP Morgan Neutral
2020-07-31 繰り返されました Chardan Capital Markets Buy
2019-09-12 開始されました Guggenheim Buy
2019-09-04 アップグレード Wells Fargo Market Perform → Outperform
2018-11-02 アップグレード Goldman Neutral → Buy
2018-08-03 繰り返されました Chardan Capital Markets Buy
2018-06-13 開始されました Argus Buy
2018-04-25 ダウングレード Wells Fargo Outperform → Market Perform
2018-01-24 開始されました Goldman Neutral
2018-01-16 繰り返されました Chardan Capital Markets Buy
2016-06-28 繰り返されました Singular Research Buy
2016-04-15 開始されました Chardan Capital Markets Buy
2016-03-28 開始されました Singular Research Buy
2016-02-19 開始されました Wells Fargo Outperform
2014-05-15 開始されました Summer Street Research Buy
2011-05-31 繰り返されました WBB Securities Strong Buy
2011-01-10 繰り返されました Wedbush Outperform
2010-11-05 繰り返されました Wedbush Outperform
2010-08-18 アップグレード WBB Securities Buy → Strong Buy
2010-08-06 繰り返されました Caris & Company Buy
すべてを表示

Emergent Biosolutions Inc (EBS) 最新ニュース

pulisher
Dec 31, 2024

Emergent BioSolutions up 10% on HC Wainwright buy initiation - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Emergent Stock Skyrockets 251% YTD: How to Play the Stock? - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

The 13% return this week takes Emergent BioSolutions' (NYSE:EBS) shareholders one-year gains to 285% - Simply Wall St

Dec 31, 2024
pulisher
Dec 31, 2024

HC Wainwright & Co. Initiates Coverage of Emergent BioSolutions (EBS) with Buy Recommendation - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Emergent BioSolutions stock leverages NARCAN and vaccine sales for long-term potential - Investing.com Canada

Dec 31, 2024
pulisher
Dec 30, 2024

Emergent BioSolutions (EBS) Stock Surge Explained - GuruFocus.com

Dec 30, 2024
pulisher
Dec 30, 2024

Why Emergent BioSolutions Stock Blasted Higher Today - MSN

Dec 30, 2024
pulisher
Dec 30, 2024

Emergent BioSolutions (NYSE:EBS) Stock Price Up 11.9%What's Next? - MarketBeat

Dec 30, 2024
pulisher
Dec 30, 2024

Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 30, 2024
pulisher
Dec 30, 2024

Emergent BioSolutions (NYSE:EBS) Coverage Initiated at HC Wainwright - MarketBeat

Dec 30, 2024
pulisher
Dec 28, 2024

Emergent BioSolutions (NYSE:EBS) Stock Rating Lowered by StockNews.com - MarketBeat

Dec 28, 2024
pulisher
Dec 25, 2024

State Street Corp Has $15.96 Million Stock Holdings in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Dec 25, 2024
pulisher
Dec 24, 2024

Kenvue to Replace Advance Auto Parts in S&P 500; Emergent BioSolutions to be Removed From S&P SmallCap 600 - Marketscreener.com

Dec 24, 2024
pulisher
Dec 21, 2024

Emergent Bio's smallpox vaccine gets US approval for mpox - AOL

Dec 21, 2024
pulisher
Dec 20, 2024

Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine - MSN

Dec 20, 2024
pulisher
Dec 20, 2024

Emergent BioSolutions (NYSE:EBS) Downgraded by StockNews.com to Hold - MarketBeat

Dec 20, 2024
pulisher
Dec 17, 2024

Emergent BioSolutions receives $50 million contract option from BARDA - MSN

Dec 17, 2024
pulisher
Dec 17, 2024

Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by BNP Paribas Financial Markets - MarketBeat

Dec 17, 2024
pulisher
Dec 17, 2024

Emergent BioSolutions Inc. Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) - Marketscreener.com

Dec 17, 2024
pulisher
Dec 16, 2024

Emergent secures $50 million BARDA anthrax vaccine contract By Investing.com - Investing.com Australia

Dec 16, 2024
pulisher
Dec 16, 2024

Emergent BioSolutions Receives $50 Million Contract Option from BARDA - citybiz

Dec 16, 2024
pulisher
Dec 16, 2024

Emergent secures $50 million BARDA anthrax vaccine contract - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) - The Manila Times

Dec 16, 2024
pulisher
Dec 16, 2024

Emergent BioSolutions Lands $50M BARDA Contract for FDA-Approved Anthrax Vaccine CYFENDUS - StockTitan

Dec 16, 2024
pulisher
Dec 11, 2024

Know Future Outlook of Vaccine Conjugates Market: Key Players Sanofi Pasteur, Emergent BioSolutions - openPR

Dec 11, 2024
pulisher
Dec 10, 2024

Oak Hill Advisors LP Invests $9.30 Million in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions - Benzinga

Dec 09, 2024
pulisher
Dec 09, 2024

Shigella Infections Market: Projected to Expand Significantly - openPR

Dec 09, 2024
pulisher
Dec 09, 2024

Jacobs Levy Equity Management Inc. Invests $1.55 Million in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Emergent to sell Baltimore-Camden production site for $30M - MSN

Dec 09, 2024
pulisher
Dec 07, 2024

Point72 Asia Singapore Pte. Ltd. Decreases Stake in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Charles Schwab Investment Management Inc. Decreases Stake in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

Institutional investors in Emergent BioSolutions Inc. (NYSE:EBS) lost 9.5% last week but have reaped the benefits of longer-term growth - Simply Wall St

Dec 06, 2024
pulisher
Dec 03, 2024

Emergent BioSolutions (EBS) Shares Fall Amidst Institutional Sel - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Why Emergent BioSciences Stock Plummeted Today - Yahoo! Voices

Dec 03, 2024
pulisher
Dec 02, 2024

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook (SIGA) - Seeking Alpha

Dec 02, 2024
pulisher
Nov 30, 2024

Emergent BioSolutions (FRA:ER4) Total Liabilities : €873 Mil (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 23, 2024

GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks - MSN

Nov 23, 2024
pulisher
Nov 22, 2024

Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement - Benzinga

Nov 22, 2024
pulisher
Nov 20, 2024

Emergent BioSolutions Inc. (NYSE:EBS) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

Insider Sale: Director Donald Degolyer Sells 25,000 Shares of Em - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Emergent BioSolutions director Donald DeGolyer sells $272,750 in stock - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Emergent BioSolutions director Donald DeGolyer sells $272,750 in stock By Investing.com - Investing.com UK

Nov 14, 2024
pulisher
Nov 14, 2024

Insider Sale: Director Marvin White Sells 14,287 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Oak Hill Advisors LP's Strategic Acquisition of Emergent BioSolu - GuruFocus.com

Nov 13, 2024

Emergent Biosolutions Inc (EBS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$11.98
price down icon 0.58%
$91.21
price up icon 2.71%
$83.72
price down icon 0.62%
drug_manufacturers_specialty_generic RDY
$15.44
price down icon 1.47%
$138.10
price up icon 0.17%
$12.28
price down icon 1.13%
大文字化:     |  ボリューム (24 時間):